HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

apremilast

a PDE4 inhibitor
Also Known As:
CC 10004; CC-10004; CC10004
Networked: 85 relevant articles (23 outcomes, 31 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Day, Robert M: 6 articles (01/2016 - 08/2012)
2. Tencer, T: 6 articles (11/2015 - 11/2015)
3. Schett, Georg: 6 articles (09/2015 - 10/2010)
4. Stevens, Randall M: 6 articles (07/2015 - 10/2010)
5. Hu, ChiaChi: 5 articles (07/2015 - 08/2012)
6. Capri, S: 4 articles (11/2015 - 11/2015)
7. Caloto, T: 4 articles (11/2015 - 11/2015)
8. Oskar, B: 4 articles (11/2015 - 11/2015)
9. Barbieri, M: 4 articles (11/2015 - 11/2015)
10. Kavanaugh, Arthur: 4 articles (06/2015 - 01/2014)

Related Diseases

1. Psoriasis (Pustulosis Palmaris et Plantaris)
2. Psoriatic Arthritis
3. Atopic Dermatitis (Atopic Eczema)
4. Asthma (Bronchial Asthma)
5. Pruritus (Itching)

Related Drugs and Biologics

1. Phosphodiesterase 4 Inhibitors
2. Type 4 Cyclic Nucleotide Phosphodiesterases
3. Roflumilast
4. 6- ((3- ((dimethylamino)carbonyl)phenyl)sulfonyl)- 8- methyl- 4- ((3- methyloxyphenyl)amino)- 3- quinolinecarboxamide
5. cipamfylline
6. Interleukin-23 (Interleukin 23)
7. adalimumab (Humira)
8. Interleukin-12 (IL 12)
9. AN2728
10. Methotrexate (Mexate)

Related Therapies and Procedures

1. Biological Therapy